Veloxis Pharmaceuticals announces financial results for the first half 2012, anticipated financing, revised EU …

HORSHOLM, Denmark, Aug. 22, 2012 /PRNewswire/ --Highlights:Veloxis development activities for LCP-Tacro™ are proceeding in line with expectations.  Enrollment has been completed in the pivotal LCP-Tacro ...